Greetings, Traders,
Today I would like to introduce an amazing life-saving medical technology to your attention… and it's on the verge of entering international commercialization.
I have been doing some research on this company which has a patented medical device that could be a revolutionary force in the healthcare industry.
And, the solutions and services provided by this company have a market potential of over a billion dollars in the U.S. alone. The international market potential is substantially larger.
My New Revolutionary Medical Breakthrough Technology Play is…
*** Medisafe 1 Technologies Corp. (OTCBB: MFTH)***
MFTH (Medisafe 1 Technologies) has the world’s FIRST U.S. patented technology to eliminate administration of incorrect medications that are injected by hypodermic needles!
Specifically, Medisafe has an ingenious “protector device” that fits over the portion of a syrnge.
This protector device has a locking mechanism which ensures that when injecting a patient, only the correct medicine is released from the hypodermic needle after positive technology-based pre-matching of the prescribed medicine is verified with the specific patient.
The technology uses a barcode technology on the locking element which allows a doctor or nurse to release the medicine upon confirming a positive match.
So, Medisafe’s patented technology ensures that medications cannot be released from hypodermic needles without positive pre-matching between the medicine and its intended patient.
-------------------------
Medisafe's Medical Technology Could Solve a HUGE Worldwide Problem
To give everyone an idea about how revolutionary this first-to-market, one-of-a-kind technology could be, check out the following statistics:
-
The direct annual cost of preventable drug related mortality & morbidity is over one hundred seventy billion
-
1,000,000 people world-wide are injured from medical errors
-
There are 400,000 preventable drug related injuries per year and 7,000 deaths each year
-
Up to 98,000 Americans die each year due to medical errors by healthcare professionals
-
There is at least one medication error per hospital patient per day (Institute of Medicine)
As you could see from the statistics above, this market has STAGGERING revenue generating potential … and the demand for a life-saving technology of this magnitude could be tremendous from hospitals and medical facilities worldwide.
In fact, this situation has essentially developed into a global epidemic that is gaining tremendous attention by the worldwide community…
Hence, this is why MFTH is positioned to experience high growth as its products and services are being increasingly looked at from around the world.
-----------------------------------------
Top 5 Investor Highlights
#1. Medisafe has developed a solution to a several hundred billion dollar world healthcare issue.
#2. MFTH has the potential to be the biggest company in this sector as it was the first to patent its technology!
#3. Medisafe is developing an increase interest in its products as it meets with world-wide governments to showcase its solutions.
#4. Medisafe intends to begin licensing the technology to commercial entities during the first quarter of 2011.
#5. MFTH is currently in discussions with the United States and a major Israeli pharmaceutical company to begin the implementation of its technology.
------------------------------------------
MFTH is the Solution…
MFTH began public trading on the OTC Bulleting Board just five months ago.
So, considering this is a Company with tremendous life-saving capabilities with immediate applications, we could be on to something huge.
In the months since MFTH began trading, the company has made several noteworthy announcements demonstrating the ability of the management team to develop its patented syringe locking device, and to successfully demonstrate the effectiveness and commercialization of the product.
The locking device has garnered significant interest from noteworthy entities, who are interested in employing the technology in hospitals to reduce loss of life through avoidable human errors, and in turn reduce hospital operating expenses.
-------------------------------
Watch MFTH (Medisafe 1 Technologies) trade, especially since a surge in volume could catapult share prices significantly.
I'm looking for solid double-digit gains in the immediate near-term for Medisafe based upon the fact that:
(1) Fundamentally, MFTH looks like it's healthcare technology breakthrough could generate excellent earnings for the Company.
(2) Technically, shares are trading right around the 20-day exponential moving average, which is right in between the upper and lower Bollinger band, suggesting there could be a lot of room for shares to increase.
(3) MFTH has made big moves recently when volume enters, something that I confidently expect we could see during Monday's trading session, resulting in shares witnessing an explosive surge upwards.
Watch for a bull rally on MFTH and the potential for excellent returns upon an increase in buying pressure that spikes share prices to higher levels.
info@supernovastockpicks.com
www.supernovastockpicks.com
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. ****************************************************************************************************************** The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: The SuperNovaStockPicks employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.supernovastockpicks.com/disclaimer Release of Liability: Through use of this website viewing or using you agree to hold SuperNovaStockPicks, its operators owners and employees harmless and to compltely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SuperNovaStockPicks's affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SuperNovaStockPicks has been compensated seventeen thousand five hundred thousand dollars for a one day investor awareness marketing campaign by Equities Awareness Group. All information on featured companies is provided by the companies profiled, or is available from public sources and SuperNovaStockPicks makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to or sell any securities. Any claims or Statements should be deemed apocryphal. SuperNovaStockPicks, nor any of its affiliates are not registered investment advisors or a broker dealers.SuperNovaStockPicks encourages readers and investors to supplement the information in these reports with independent research and other pro advice. SuperNovaStockPicks encourages readers and investors to supplement the information in these reports with independent research and other pro advice.
